April 19, 2026 10:26 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pushback from smartphone makers: Centre drops Aadhaar app pre-install plan — report | Meta eyes first wave of layoffs on May 20: Report | TCS breaks silence on Nida Khan: ‘No HR role, no power’ in Nashik case | ‘Panic reaction’: Rahul Gandhi on women’s bill, says PM Modi ‘wants to send a message’ | Adani Group shares rise as Gautam Adani becomes Asia’s richest, overtakes Mukesh Ambani | TCS Nashik ‘conversion’ case accused seeks anticipatory bail citing pregnancy | IT raids TMC candidate Debasish Kumar’s premises ahead of Bengal polls | Bengal SIR: Supreme Court allows voters restored by tribunal till April 21 and 27 to vote | 'Women won't spare you': PM Modi warns Opposition over resistance to quota bill | Vijay booked in 3 cases over poll code violation ahead of Tamil Nadu polls
Omicron
wallpaper cave

UK approves first Covid booster vaccine targeting Omicron variants

| @indiablooms | Aug 16, 2022, at 12:34 am

London: The UK Medicines and Healthcare products Regulatory Agency said on Monday that it has approved the first COVID-19 booster vaccine developed by US-based pharmaceutical company Moderna that targets original and Omicron strains.

"An updated version of the COVID-19 vaccine made by Moderna that targets two coronavirus variants (known as a 'bivalent' vaccine) has today been approved for adult booster doses by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness," the agency said.

The name of the vaccine is Spikevax bivalent Original/Omicron. MHRA said that each dose contains 25 micrograms of Omicron vaccine and 25 micrograms of original coronavirus vaccine, which targets the strain from 2020.

The vaccine triggers a strong immune response against both strains, as well as a good immune response against sub-variants of Omicron, the agency said, adding that patients experience the same side effects as from the original Moderna booster dose.

The vaccine has been granted a conditional marketing authorization in England, Scotland and Wales, and an emergency use authorization in Northern Ireland.

MHRA Chief Executive June Raine said in the statement that the new vaccine provides "a sharpened tool in our armoury to help protect us against this disease" while the first generation of COVID-19 vaccines "continue to provide important protection."

According to UK broadcaster Sky News, the new booster vaccine has also been submitted for approval in Australia, Canada, and the European Union.

 

(With UNI inputs)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.